诱导多能干细胞:从发现走向转化
该综述回顾了诱导多能干细胞(iPSC)技术问世二十年来的发展,指出非整合重编程、高效分化、组织工程与基因组编辑的融合已推动首批iPSC治疗进入临床试验和早期批准。但生物变异性、制造复杂性与长期安全监测仍制约标准化疗法的推广,未来自动化与人工智能有望重塑iPSC工作流程。
要点
- iPSC技术已从生物学发现演变为转化性临床平台。
- 首批iPSC治疗临床试验已启动并出现早期批准。
- 生物变异性、制造复杂性与长期安全监测仍是主要障碍。
核心结论
- iPSC领域已从基础发现发展为临床转化平台,但标准化和广泛可及的治疗仍受生物变异性、制造复杂性和长期安全监测需求制约。
- 整合自动化与人工智能可能将iPSC工作流程重新定义为可扩展系统,推动iPSC衍生干预从定制实验模型转向标准化工程化生物药物。
研究设计与样本
- 本文为综述,评估定义iPSC时代的技术与转化轨迹,并分析治疗开发的操作性障碍。
主要发现
- 非整合细胞重编程、高效分化方案、高保真组织工程和精确基因组编辑的融合,建立了在人类细胞系统中重现和探究人类疾病生物学的平台级框架。
- 这些里程碑促成了首批基于iPSC的治疗性临床试验和近期的早期批准。
临床怎么用
- 临床转化需关注iPSC疗法的生物变异性、制造复杂性和长期安全监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Two decades after the introduction of induced pluripotent stem cell (iPSC) technology, the field has evolved from a seminal biological discovery into a transformative clinical platform. This maturation reflects a convergence of nonintegrating cellular reprogramming, efficient differentiation protocols, high-fidelity tissue engineering and precise genome editing-which together have established a platform-level framework for recapitulating and probing human disease biology in human cell-based systems. While these milestones have enabled the first wave of iPSC-based therapeutic clinical trials and recent early approvals, the transition to standardized, widely deployable therapies remains constrained by inherent biological variability, manufacturing complexities and the need for long-term safety surveillance. This Review evaluates the technological and translational trajectories that have defined the iPSC era and analyzes the operational barriers to therapeutic development. Looking forward, we discuss how integrating automation and artificial intelligence could redefine iPSC workflows as scalable systems. We present a roadmap for the next 20 years, envisioning a paradigm shift in which iPSC-derived interventions transition from bespoke experimental models toward standardized, engineered biological medicines.
引用
- Lee J, Herron T, Studer L, et al. Induced pluripotent stem cells from discovery to translation. Nat Med. 2026. PMID: 42661099. doi:10.1038/s41591-026-04584-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。